The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1695, doi. 10.1111/bph.16355
- By:
- Publication type:
- Article
Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 12
Results: 13
1
2
Radiprodil, a selective GluN2B negative allosteric modulator, rescues audiogenic seizures in mice carrying the GluN2A(N615S) mutation.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1886, doi. 10.1111/bph.16361
- By:
- Publication type:
- Article
3
Holotoxin A<sub>1</sub> from Apostichopus japonicus inhibited oropharyngeal and intra‐abdominal candidiasis by inducing oxidative damage in Candida albicans.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1857, doi. 10.1111/bph.16333
- By:
- Publication type:
- Article
4
Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1874, doi. 10.1111/bph.16336
- By:
- Publication type:
- Article
5
Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1843, doi. 10.1111/bph.16332
- By:
- Publication type:
- Article
6
Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1829, doi. 10.1111/bph.16329
- By:
- Publication type:
- Article
7
Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1812, doi. 10.1111/bph.16328
- By:
- Publication type:
- Article
8
Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1757, doi. 10.1111/bph.16327
- By:
- Publication type:
- Article
9
Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1720, doi. 10.1111/bph.16322
- By:
- Publication type:
- Article
10
Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1768, doi. 10.1111/bph.16320
- By:
- Publication type:
- Article
11
An orally available Ca<sub>v</sub>2.2 calcium channel inhibitor for the treatment of neuropathic pain.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1734, doi. 10.1111/bph.16309
- By:
- Publication type:
- Article
12
Voltage tunes mGlu<sub>5</sub> receptor function, impacting synaptic transmission.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1793, doi. 10.1111/bph.16317
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 12, p. 1693, doi. 10.1111/bph.16127
- Publication type:
- Article